Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
Triclabendazole for the treatment of fascioliasis and paragonimiasis
HTML
Details
Locations
Year:
2005
Type:
review
Source:
Expert Opinion on Investigational Drugs
DOI:
10.1517/13543784.14.12.1513
Authors:
Jennifer Keiser,
Dirk Engels,
Gottfried Büscher,
Jürg Utzinger
Institutions:
Swiss Tropical and Public Health Institute,
World Health Organization,
Novartis (Switzerland)
Language:
English
Topic:
Helminth infection and control
Subfield:
Parasitology
Field:
Immunology and Microbiology
Domain:
Life Sciences
Keywords:
triclabendazole,
fascioliasis,
paragonimiasis,
Fasciola,
Paragonimus,
liver fluke,
lung fluke,
benzimidazole,
praziquantel alternatives,
pharmacodynamics,
pharmacokinetics,
toxicology,
drug efficacy,
drug registration,
sanitation
show all 15
SDG:
Good health and well-being
Open Access status:
closed
Funder:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
OpenAlex ID:
W2039428342
FWCI:
1.496
Cites:
81
Cited by:
230
Related to:
10